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There are marked global disparities in the incidence of cervical cancer, 
with most cases occurring in low- and middle-income countries 
(LMICs). In high-income countries (HICs), the implementation 
of organised cytology-based cervical screening programmes has 
resulted in a decline in cervical cancer incidence and mortality rates. 
Unfortunately, cervical cancer continues to be a significant public 
health problem in LMICs owing to the lack of high-quality screening 
programmes and poor screening coverage in those regions. [1,2] 
Effective cytology-based screening requires a relatively robust 
healthcare infrastructure with functional laboratory services, well-
trained healthcare providers and technicians, good referral systems, 
and linkage to accessible treatment facilities and follow-up after 
treatment for women with abnormal screening tests. This approach 
requires resources typically not available in LMICs, hampering the 
initiation and maintenance of screening programmes.[3]
The World Health Organization has recommended molecular 
testing for human papillomavirus (HPV) as an alternative to cytology-
based screening in low-resource settings, given that these tests are 
more sensitive than cytology and visual inspection methods in detec-
ting high-grade cervical intraepithelial neoplasia and cancer. [2,4-6] A 
randomised controlled trial in India showed that in low-resource 
settings, a single round of HPV testing was associated with a 
significant reduction in cervical cancer mortality.[5] HPV tests also 
have the advantage that vaginal samples can be collected by the 
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Background. Self-sampling as a method of screening for cervical cancer and its precursors is an attractive option for low-resource settings. 
However, to allow successful integration of self-sampling into national screening programmes, it is necessary to understand women’s 
perceptions and beliefs surrounding this method of sampling the cervix.
Objectives. To explore women’s attitudes to self-collection of samples for cervical screening in a low-resource setting in South Africa 
(SA).
Methods. Mixed methods were used to meet the study objectives. We recruited women aged 30 - 65 years into a study in Cape Town, SA, 
to participate in a cross-sectional survey. All women collected a vaginal self-sample, and underwent visual inspection with acetic acid, 
colposcopy, and collection of cervical samples and appropriate histology specimens by a doctor. Women had a quantitative questionnaire-
based exit interview. A subset of these women participated in focus group discussions (FGDs).
Results. A total of 822 women answered the exit survey questionnaire and 41 women participated in the FGDs. Most women from the 
survey had a positive perception of self-sampling, with 93.6% of the women reporting not feeling embarrassed and 89.4% reporting 
experiencing no discomfort at all when taking a self-sample. This was corroborated by the FGD participants, who found self-sampling 
easier, more comfortable and less embarrassing than clinician sampling. However, many women (64.7%) felt more confident when the 
sample was taken by a clinician, despite having a positive attitude towards self-sampling. In most cases this was because they thought that 
the clinician would take a better sample, as explained by the FGD participants. Although 93.9% of the women were willing to collect a self-
sample, the women in the FGDs expressed a preference for doing so at the health facility rather than at home. There were many reasons for 
this, including the cost of returning to the clinic with the sample.
Conclusions. Attitudes regarding self-sample collection were positive in this study population. Participants were willing to perform self-
sampling, but expressed concerns regarding the quality of the specimen and the financial implications of returning to the clinic with it. Pilot 
implementation studies will be useful before this method of sampling is adopted and integrated into screening programmes.
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woman herself, which may increase coverage.[3,7] HPV DNA testing 
is therefore an attractive alternative to cytology-based screening in 
low-resource settings.
HPV testing on self-collected vaginal samples has been shown 
to be as accurate as testing on samples collected by a doctor and 
can potentially increase coverage for cervical cancer screening in 
low-resource settings.[7-12] Several studies done across the world in 
various settings suggest that self-sampling is an acceptable method of 
collecting a sample for HPV typing for most women.[3,13-16]
Objectives
To explore women’s perceptions and acceptance of self-collection of 
samples for cervical screening and their willingness to do so, in a low-
resource setting in South Africa (SA).
Methods
This mixed-methods study was part of a National Cancer Institute 
(NCI)-funded collaborative project carried out by the University 
of Cape Town, Columbia University and Cepheid Inc. (Sunnyvale, 
Calif., USA), utilising a new point-of-care CE-IVD test, Xpert HPV. 
A convergent parallel design was used in which quantitative and 
qualitative data were collected and analysed separately and then 
merged. Approval for the study was obtained from the Faculty of 
Health Sciences Human Research Ethics Committee, University of 
Cape Town (ref. no. 703/2014) and the Human Research Protection 
Office, Institutional Review Board, Columbia University (ref. no. 
AAAO3652). The subjects provided written informed consent for 
participation.
Women aged 30 - 65 years were recruited from a referral colpo-
scopy clinic and a primary care site in Cape Town, SA, from February 
2015 to May 2016. Equal numbers of HIV-positive and HIV-negative 
women were recruited. All the participants self-collected a vaginal 
sample (a Dacron swab placed into 4 mL of PreservCyt transport 
medium in a polypropylene tube) in a private room following a verbal 
explanation on how to collect the sample by a community health 
worker (CHW). All the women also underwent collection of cervical 
samples by colposcopy, followed by visual inspection of the cervix 
after application of acetic acid and collection of histology samples by 
a doctor. The study aimed to recruit roughly equal numbers of HIV-
positive and HIV-negative women.
Cross-sectional survey
All participants answered an exit questionnaire that examined the 
woman’s level of embarrassment, discomfort, confidence to carry 
out self-sampling, and feelings of being ignored by the health worker 
and of intrigue with the procedure. The response options for these 
questions were coded on a 5-point scale: 1 = ‘extremely’, 2 = ‘very’, 
3 = ‘moderately’, 4 = ‘slightly’, 5 = ‘not at all’. The responses to the 
questions regarding ‘confidence to carry out self-sampling’ and 
‘whether they felt intrigued’ were reverse-coded (1 = ‘not at all’, 2 = 
‘slightly’, 3 = ‘moderately’, 4 = ‘very’, 5 = ‘extremely’) for accurate 
interpretation. Questions on collection method preference (whether 
they prefered self-sampling, clinician sampling or had no preference 
for either method) and whether they were willing to take a self-
sample at home were also included in the questionnaire.
Descriptive statistics were used to describe the respondents’ 
demographic profile and response to the exit questionnaire. The χ2 
test was used to compare categorical variables and the Kruskal-Wallis 
test for continuous variables. Variables that were significant in the 
bivariate analysis were included in a multinomial logistic regression 
model to investigate independent predictors of sampling preference. 
The differences were statistically significant at p<0.05 (two-sided). 
The data analysis was performed using SPSS 23 (IBM, USA)
Focus group discussions
Six focus group discussions (FGDs) were conducted at the primary 
healthcare study site. Each group consisted of 6 - 7 participants, 
considered the minimum number required to elicit meaningful 
dialogue and discussion. All FGDs took place once participants had 
completed all the clinical assessments. Written informed consent 
for the FGD was obtained from all participants. Discussions lasted 
between 45 and 60 minutes. An interview guide was used for 
the FGDs, which were facilitated by a female trained qualitative 
researcher with the assistance of a translator (discussions were 
conducted in isiXhosa and were digitally recorded, translated and 
transcribed verbatim).
The health belief model (HBM) theory[17] was employed to 
construct exploratory themes for the FGDs. The themes explored 
included individual and community understanding of cervical 
cancer; perceived risk of and susceptibility to cervical cancer; 
perceived individual and community barriers to and benefits of Pap 
smears; women’s experience with self-sampling (including preceding 
anxiety/fears/concerns, ease or difficulty of the procedure, associated 
pain and/or discomfort, confidence in collecting sample, perceived 
individual and community barriers, and benefits of self-sampling); 
self-sample collection preference (i.e. provider or self-collected); site 
preference (at home or at the clinic) and reasons for preference; and 
suggestions on how to facilitate self-sampling.
The transcripts were reviewed, and data were entered on QSR 
Nvivo10,[18] a software package designed for systematic management 
and analysis of qualitative data. Initial coding categories were based on 
the interview guides and from the theoretical concepts of the HBM. 
Once all the text segments had been given basic codes, the codes were 
categorised into basic themes by placing similar codes together. For 
this study, only themes related to self-sampling were analysed.
Results
Results from the quantitative and qualitative research were reviewed 
to seek corroboration, to clarify results from the quantitative research 
and vice versa, and to extend the breadth of our understanding.
Sociodemographic characteristics
The cross-sectional survey included 822 women, with a median age 
of 41 years (interquartile range (IQR) 35 - 49) and median parity of 2 
(IQR 2 - 3). Most of the women had a secondary education (78.4%), 
80.0% had had a previous Pap smear, and 78.6% were non-smokers. 
More than half of the participants (54.1%) used some form of 
contraception, and 42.3% tested positive for HIV. Forty-one women 
were enrolled and participated in the FGDs (mean age 41  years, 
range 30 - 62).
Acceptability of self-sampling
Table 1 reports on participant perceptions of self- and clinician 
sampling elicited during the cross-sectional survey. A higher 
proportion of women reported that they did not feel embarrassed 
at all taking the self-sample (93.6%) compared with those reporting 
no embarrassment having the doctor collect the sample (88.2%) 
(p=0.0002). Mean Likert scores for embarrassment (Table 2) also 
showed that women were significantly less embarrassed to self-
sample compared with sampling by a doctor. The proportion who 
reported feeling no discomfort at all was greater for the self-collected 
(89.4%) v. the doctor-collected sample (56.0%) (p<0.001), with 
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significant differences in the mean Likert scores (Table 2). Women 
were more confident when the sample was taken by a clinician 
(64.7%) rather than by self-sampling (59.5%) (p=0.03), also with 
significant differences in the mean Likert score. These findings were 
corroborated during the FGDs, as illustrated by the quotes below.
 ‘I prefer doing it [self-sample] myself; to me, it was easier than 
having someone else doing it to me.’ (FGD1)
 ‘It was [more] comfortable to do the self-sampling myself than to 
be done by the doctor.’ (FGD6)
 ‘I would choose to do it [sample] myself because I get embarrassed 
to expose myself to the doctor.’ (FGD2)
Instructions on self-sampling procedure
This was explored in the FGDs only. All the women thought that 
the CHWs’ verbal explanation of how to perform the self-sample 
procedure was sufficient and could not think of ways in which 
the description of the procedure could be improved. When asked 
whether diagrams or illustrations would be useful, mixed views 
were expressed. Most women did not think it would be beneficial to 
include diagrams and preferred a verbal explanation only. Some felt 
that pictures would be disturbing.
 ‘Those pictures of cervix and wombs are scary.’ (FGD 6)
Some women, however, did think the use of diagrams and illustrations 
would be helpful.
 ‘I would prefer an explanation and a diagram because the doctor 
will explain and at the same time show you on the picture how to 
do it [self-sample].’ (FGD 4)
All participants noted the importance of using simple and easy-to-
understand expressions when explaining how to perform the self-
sampling. While some thought that an explanation in English would 
be acceptable, the majority would prefer the explanation to be given 
in their mother tongue.
Sampling method preference
In the cross-sectional survey, more women (45.1%) preferred their 
cervical sample to be taken by the clinician, while 33.8% preferred 
self-sampling and 21.0% did not have a preference for one method 
over the other. FGD participants gave more insight into why the 
participants preferred the health worker to take the sample rather 
than to self-sample. Those who preferred the sample to be taken by 
a health worker justified their choice by stating that the doctor is a 
trained professional and therefore more capable of taking the sample. 
Furthermore, he or she could also investigate, identify and treat any 
other abnormalities that the patient might not be able to see.
 ‘I would rather have a doctor do it [sample]. When she opens down 
there, she can examine and see other things inside down there, 
which I would not be able to notice myself.’ (FGD 5)
However, some of the women who preferred taking the sample 
themselves stated that when the health worker collected the sample 
they found it painful and were embarrassed.
We further analysed the cross-sectional data to see the relationship 
between sampling method preference and the demographic variables 
of the respondents. On bivariate analysis, women with a tertiary level 
of education and HIV-negative women were significantly more likely 
to prefer self-sampling to clinician sampling, while women who were 
not on any form of contraception and those who lived in informal 
settlements were significantly more likely to prefer clinician sampling 
(Table 3).
A multinomial logistic regression analysis that included age 
categories, education level, type of housing, HIV status, smoking 
and contraceptive use was performed to determine the predictive 
factors of sampling preference (self-sampling, clinician sampling or 
no preference for method). The reference group was those women 
with preference for the clinician sampling method. Accordingly, each 
predictive factor has two parameters, one for predicting preference for 
self-sampling rather than clinician sampling and one for predicting 
no preference for either method. Women who used contraception 
and those who smoked were ~1.5 times more likely and those living 
in houses they owned twice as likely to prefer self-sampling to 
clinician sampling. Women with primary education and above were 
~3 times and HIV-positive women ~1.5 times more likely to prefer 
clinician sampling to self-sampling or to have no preference for either 
method (Table 4).
Table 1. Frequency of perceptions of self-sampling and clinician sampling among 822 women who completed the exit interview, 
scored on a Likert scale
Perception Method 1 (extremely) 2 (very) 3 (moderately) 4 (slightly) 5 (not at all)
Embarrassed Self-sample 3 (0.4) 3 (0.4) 8 (1.0) 39 (4.7) 769 (93.6)
Clinician sample 15 (1.8) 6 (0.7) 15 (1.8) 60 (7.3) 726 (88.3)
Confident Self-sample 489 (59.5) 112 (13.6) 110 (13.4) 39 (4.7) 72 (8.8)
Clinician sample 532 (64.7) 134 (16.3) 77 (9.4) 32 (3.9) 47 (5.7)
Discomfort Self-sample 2 (0.2) 9 (1.1) 16 (2.0) 60 (7.3) 735 (89.4)
Clinician sample 14 (1.7) 11 (1.3) 50 (6.1) 287 (34.9) 460 (56.0)
Ignored Self-sample 13 (1.6) 1 (0.1) 0 6 (0.7) 802 (97.6)
Clinician sample 15 (1.8) 0 1 (0.1) 2 (0.2) 804 (97.8)
Intrigued Self-sample 709 (86.3) 67 (8.2) 27 (3.3) 9 (1.1) 10 (1.2)
Clinician sample 705 (85.8) 68 (8.3) 22 (2.7) 7 (0.8) 20 (2.4)
Table 2. Mean Likert scale scores for perceptions of self-
sampling and clinician sampling among 822 women who 
completed the exit interview
Acceptability 
measure on a 





Embarrassed 4.91 (0.41) 4.79 (0.68) 0.0005
Discomfort 4.84 (0.52) 4.42 (0.81) 0.0005
Ignored 4.93 (0.52) 4.92 (0.54) 0.89
Confident* 4.10 (1.3) 4.92 (0.54) 0.0005
Intrigued* 4.77 (0.68) 4.74 (0.79) 0.41
SD = standard deviation.
*Reverse-coded for purposes of analysis.
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In multivariable analysis, educational status, contraceptive use and 
HIV status remained significant. Type of housing was no longer 
significant in the multivariable model.
Willingness to self-sample at home
The majority (93.9%) of the women who participated in the cross-
sectional survey said that they would be willing to self-sample at 
home. Going deeper into this discussion during the FGDs, many 
women mentioned that the idea of collecting the self-sample at home 
was appealing, because of home comfort. Even those who lived in 
crowded homes said that they would be able to find a space to take 
the sample. When asked how they would feel if somebody saw them 
taking the self-sample or found the self-sample at home, most felt 
confident that they would be able to explain what they were doing 
and why they were taking the sample.
 ‘It’s like the same as putting a tampon, if someone sees you putting 
it they have the same reaction, and you explain.’ (FGD 5)
However, during the FGDs when women were told that the self-
sample collected at home would need to be returned to the health 
facility, most suggested that they would then prefer to collect the self-
sample at the clinic instead. Reasons for choosing to do so included 
costs associated with having to come to the clinic twice, while having 
a health professional at hand who could give reassurance if needed 
was also important for some. Some women also raised concerns 
about specimen contamination and the possibility of forgetting or 
being unable to return it to the clinic in time.
 ‘It’s waste of time and money coming here and going home and 
coming back here again whereas I could have done everything here 
all at once.’ (FGD 5)
 ‘It will also depend on having money to come back to the clinic, if 
I have money then I will come.’ (FGD 5)
 ‘I would be worried about something getting into the sample and 
contaminating it.’ (FGD 3)
 ‘I would worry about it getting dry before bringing it back.’ (FGD 5)
Discussion
In this study, we integrated questionnaire-based interviews, which 
were used to determine individual experiences of the patients of both 
self-sampling and clinician-collected sampling, with FGDs, which 
were used to obtain an in-depth discussion to understand their beliefs 
and opinions with regards to self-sampling.
As described in Table 1, and corroborated by the findings in the 
FGDs, even though there was initial surprise when women were 
asked to take the sample, they had more positive perceptions about 
self-sampling than clinician sampling, most notably regarding less 
embarrassment and discomfort when self-collecting the sample. 
Previous studies have noted similar findings from both HICs and 
LMICs.[3,12-15] However, women were significantly less confident 
about the quality of the self-collected sample compared with the 
clinican-collected sample. This lack of confidence in self-sampling 
has been reported in previous studies.[19,20] Incorporating additional 
information to assure women that self-sampling does not compromise 
the quality of the sample and that many studies have found self-








Age group (years), n (%) 0.99
30 - 39 123 (44.2) 167 (45.0) 78 (45.1)
40 - 49 86 (30.9) 117 (31.5) 57 (32.9)
50 - 59 55 (19.8) 71 (19.1) 30 (17.3)
≥60 14 (5.0) 16 (4.3) 8 (4.6)
Education, n (%) 0.045
None 3 (1.1) 5 (1.3) 3 (1.7)
Primary 37 (13.3) 47 (12.7) 22 (12.7)
Secondary 207 (74.5) 304 (81.9) 133 (76.9)
Tertiary 31 (11.2) 15 (4.0) 15 (8.7)
House, n (%) 0.02
Informal 71 (25.5) 132 (35.6) 45 (26.2)
Formal 155 (55.8) 196 (52.8) 101 (58.7)
Owns house 33 (11.9) 21 (5.7) 15 (8.7)
Other 19 (6.8) 21 (5.7) 12 (7.0)
Smoking, n (%) 0.02
Never smoked 204 (73.4) 306 (82.5) 136 (78.6)
Current/former 74 (26.6) 65 (17.5) 37 (21.4)
HIV, n (%) 0.001
Positive 93 (33.5) 173 (46.6) 82 (47.4)
Negative 185 (66.5) 198 (53.6) 91 (52.6)
Contraceptives, n (%) 0.005
Yes 145 (52.2) 148 (39.9) 85 (49.1)
No 133 (47.8) 223 (60.1) 88 (50.9)
Previous Pap smear, n (%) 0.31
Yes 231 (83.1) 292 (79.0) 135 (78.0)
No 47 (16.9) 78 (21.0) 38 (22.0)
51       January 2019, Vol. 109, No. 1
RESEARCH
sampling to be as reliable as clinician sampling may help boost their 
confidence to obtain a self-sample.[7,8,10,11]
Despite acceptability of the self-sampling method, about half of 
the women overall (45.1%) preferred the samples to be collected 
by the clinician. Anhang et al.[21] reported similar findings in 2005 
among Hispanic women in New York City, where there was an 
overwhelming acceptance of self-sampling, but more preference for 
clinician sampling. In the FGDs, some participants expressed concern 
about their ability to take a high-quality sample and would therefore 
prefer a clinician to obtain it. Others were worried about performing 
the procedure incorrectly and causing harm. Still others expressed 
that they would prefer the sample to be collected by a health worker, 
who apart from taking a good-quality sample would also be able 
to detect and investigate any abnormalities the patient might be 
unable to identify. Previous studies have found similar concerns in 
various groups of women.[12-14,16,19] In the present study, HIV-negative 
women and women using contraception were more likely to prefer 
self-sampling, while HIV-positive women were more likely to prefer 
clinician sampling. Many HIV-positive women in SA have access to 
reproductive healthcare services integrated into the antiretroviral 
(ARV) programmes and trust their caregivers, and may therefore feel 
safer and more confident if a health worker takes the sample.
Many women from both the survey and the FGDs found the 
idea of performing the self-sampling procedure at home appealing 
despite sometimes having unfavourable home settings. However, the 
realisation during FGDs that they would need to return the specimen 
to the clinic was a deterrent to home self-sampling. Women raised 
concerns about specimen contamination, being unable to return the 
sample to the health centre in time, the cost of making two clinic 
visits, having to take additional time off work, and not having a 
health professional at hand to help and give reassurance if needed. 
It is worth noting that self-sampling in the health facility has the 
potential to reduce patient load on the limited number of health 
personnel in poorly staffed clinics and reduce patient waiting times 
in overcrowded clinics.
Conclusion
This study has highlighted positive perceptions of self-sampling for 
cervical cancer screening in this low-resource setting. Concerns 
raised by the women could be addressed by appropriate health 
education and counselling on self-sampling. The study highlighted 
some limitations to collecting self-samples at home in this 
environment. However, many health centres in developing countries 
have insufficient human resources to collect cervical samples from all 
women who require screening. In this situation, self-sampling in the 
health facility may contribute significantly to reducing long waiting 
times and congestion in health centres. Pilot implementation studies 
are needed to determine how best to incorporate this approach in 
national screening programmes
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Age (years)
30 - 39 0.646 0.825 0.36 - 1.86 0.643 0.798 0.31 - 2.07
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